Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript August 7, 2023
Enanta Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.86 EPS, expectations were $2.38.
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals’ Fiscal Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. There will be a question-and-answer session at the end of prepared remarks. Please be advised that this call...
